Trial intelligence / Profile preview

Donepezil for Motor Recovery in Acute Stroke

NCT01442766Phase 2Withdrawn

Sponsor
Imperial College London
Start
Nov 2011
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in acute stroke comparing Donepezil with Placebo (2 arms). Primary endpoint: Upper Extremity Fugl-Meyer Motor Score at 12 weeks. Planned start Nov 2011; status: withdrawn.

02

Drugs

donepezil
03

Conditions

acute stroke

Beyond the preview

Go deeper on NCT01442766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01442766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call